tuhurabio.com (HURA): Forvard P/S multiplikatori

TuHURA Biosciences, Inc. (HURA) korporativ emblemasi va logotipi

Qattiq o'smalarga yo'naltirilgan dasturlarning xilma-xilligi tartibga soluvchi o'zgarishlar xatarlarini minimallashtiradi, bu esa TuHURA Biosciences, Inc. (HURA) kompaniyasining oldingi P/S ko'rsatkichi bilan tasdiqlanadi, bunda metriki ushbu darajani belgilaydi. Saraton hujayralarini "niqoblash"ning innovatsion texnologiyasi immun tizimiga patologiyalarni samarali yo'q qilish imkonini beradi. Shu bilan birga, kompaniyaning ekologik strategiyasi standart laboratoriya xavfsizligi normalari va ofislarda energiyani tejash bilan cheklangan.

HURA (TuHURA Biosciences Inc.) Forvard P/S multiplikatori tarixi 04.07.2022dan 16.11.2026gacha

TuHURA (HURA) kompaniyasi koʻrsatkichlari kesimi va tahlili

Kompaniyaning jamlanma tahlili:tuhurabio.com HURA
TuHURA Biosciences Inc. tovar namunasi

Prognoz qilinayotgan P/S koeffitsiyenti investitsiyalarning ishonchlilik ko'rsatkichi bo'lib xizmat qiladi va qisqa muddatli bozor tebranishlarini filtrlash uchun TuHURA Biosciences, Inc. (HURA) kompaniyasining joriy bozor qiymatini kutilayotgan yillik daromadlar bilan solishtiradi. Ushbu prognoz qilinayotgan P/S grafigini tahlil qilish orqali investor tekislangan baholash dinamikasini kuzatishi mumkin, bu esa kompaniyaning patent portfeli va strategik kapitali bilan birgalikda saratonga qarshi vaksinalarning bozorga chiqarilishi davrida biznesning barqarorligini tasdiqlaydi.

TuHURA Biosciences, Inc. kimlar bilan raqobatlashadi

Forvard P/S multiplikatori ONC (BeiGene Oncology)|Forvard P/S multiplikatori Halozyme Corp HALO|RVMD: Forvard narx/daromad multiplikatori|Ascentage Pharma Group (AAPG) - Forvard narx/daromad multiplikatori|CG Oncology Therapeutics (CGON) - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati UroGen Pharma URGN|Narxning prognoz qilingan daromadga nisbati Bicara Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Personalis Genomics PSNL|Forvard P/S multiplikatori ERAS|Narxning kutilayotgan daromadga nisbati DCTH|Y-mAbs Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Aura Biosciences Inc (AURA)|CADL: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ARAY (Accuray Inc.)|SLS: Forvard P/S multiplikatori|ACTU: Narxning kutilayotgan daromadga nisbati|CTOR (Citius Oncology Inc.) - Forvard P/S multiplikatori|TARA: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Fate Therapeutics (FATE)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Aadi Bioscience|Narxning prognoz qilingan daromadga nisbati TScan Therapeutics Inc TCRX|CSBR: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|XBIT: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx CVM (cel-sci.com)|OSTX: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Radiopharm Theranostics Ltd (RADX)|ARTV (Artiva) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ANL (Adlai Nortye)|Narxning prognoz qilingan daromadga nisbati Veru Pharma (VERU)|Forvard P/S multiplikatori Tempest Tx (TPST)|Narxning prognoz qilingan daromadga nisbati xiliotx.com XLO|Enochian BioSciences - Narxning prognoz qilingan daromadga nisbati|Mural Oncology - Forvard P/S multiplikatori|KAPA - Forvard P/S multiplikatori|OnKure Therapeutics Inc (OKUR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori CytoMed|Narxning prognoz qilingan daromadga nisbati curis.com|Forvard narx/daromad multiplikatori Apollomics, Inc. (APLM)|Forvard P/S multiplikatori THAR|Advanced Biomed Corp - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Genprex GNPX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Calidi Bio (CLDI)|sunshinebiopharma.com - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati xeneticbio.com|salariuspharma.com (SLRX) - Narxning prognoz qilingan daromadga nisbati|Purple Biotech Ltd. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati AON|Forvard P/S multiplikatori BeiGene Ltd.|Narxning prognoz qilingan daromadga nisbati Checkpoint Therapeutics, Inc. (CKPT)|Forvard narx/daromad multiplikatori Elevation Oncology, Inc. ELEV|Forvard P/S multiplikatori ICAD (iCAD Inc.)|IKNA - Forvard narx/daromad multiplikatori|NTBL: Forvard narx/daromad multiplikatori|viracta.com (VIRX) - Forvard narx/daromad multiplikatori|MorphoSys (MOR) - Narxning prognoz qilingan daromadga nisbati|NAYA Biosciences Corp (NAYA) - Forvard P/S multiplikatori|AAPGV (Ascentage) - Forvard P/S multiplikatori